Remembering 911- A Genetics’ company’s response to the September 11th tragedy.
Inside the GENOME
English - April 25, 2022 06:00 - 34 minutes - 23.4 MBMedicine Health & Fitness Science genetics oncology cancer hereditary testing genetic testing brca cancer genetics Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
It has been more than twenty years since the collapse of the World Trade Center on September 11th, 2001. Dr. Slavin discusses Myriad Genetics’ company-wide involvement in the effort to help identify victims of the tragedy with John Ryan, Sr. VP of Operations, Women’s Health and Oncology, and Benoît Leclair, Program Director of Quality Assurance and Regulatory Affairs.